Global Clinical Next-Generation Sequencing Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 143970
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 123
  • list Pharmaceuticals and Healthcare

Next-generation sequencing (NGS) has been rapidly integrated into molecular pathology, dramatically increasing the breadth genomic of information available to oncologists and their patientseration sequencing.

Scope of the Report:

The global Clinical Next-Generation Sequencing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Clinical Next-Generation Sequencing.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Clinical Next-Generation Sequencing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Clinical Next-Generation Sequencing market by product type and applications/end industries.

Market Segment by Companies, this report covers

Thermo Fisher Scientific

PerkinElmer

Illumina

Beckman Coulter

GATC Biotech

Qiagen

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Targeted Sequencing

Exome Sequencing

Others

Market Segment by Applications, can be divided into

Hospitals and Clinics

Biopharma Companies

Academic and Research Organizations

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Clinical Next-Generation Sequencing Market Overview

1.1 Product Overview and Scope of Clinical Next-Generation Sequencing

1.2 Classification of Clinical Next-Generation Sequencing by Types

1.2.1 Global Clinical Next-Generation Sequencing Revenue Comparison by Types (2019-2024)

1.2.2 Global Clinical Next-Generation Sequencing Revenue Market Share by Types in 2018

1.2.3 Targeted Sequencing

1.2.4 Exome Sequencing

1.2.5 Others

1.3 Global Clinical Next-Generation Sequencing Market by Application

1.3.1 Global Clinical Next-Generation Sequencing Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Hospitals and Clinics

1.3.3 Biopharma Companies

1.3.4 Academic and Research Organizations

1.3.5 Others

1.4 Global Clinical Next-Generation Sequencing Market by Regions

1.4.1 Global Clinical Next-Generation Sequencing Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Clinical Next-Generation Sequencing Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Clinical Next-Generation Sequencing Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Clinical Next-Generation Sequencing Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Clinical Next-Generation Sequencing Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Clinical Next-Generation Sequencing Status and Prospect (2014-2024)

1.5 Global Market Size of Clinical Next-Generation Sequencing (2014-2024)

2 Manufacturers Profiles

2.1 Thermo Fisher Scientific

2.1.1 Business Overview

2.1.2 Clinical Next-Generation Sequencing Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.2 PerkinElmer

2.2.1 Business Overview

2.2.2 Clinical Next-Generation Sequencing Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 PerkinElmer Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.3 Illumina

2.3.1 Business Overview

2.3.2 Clinical Next-Generation Sequencing Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Illumina Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.4 Beckman Coulter

2.4.1 Business Overview

2.4.2 Clinical Next-Generation Sequencing Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Beckman Coulter Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.5 GATC Biotech

2.5.1 Business Overview

2.5.2 Clinical Next-Generation Sequencing Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 GATC Biotech Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.6 Qiagen

2.6.1 Business Overview

2.6.2 Clinical Next-Generation Sequencing Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Qiagen Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

3 Global Clinical Next-Generation Sequencing Market Competition, by Players

3.1 Global Clinical Next-Generation Sequencing Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Clinical Next-Generation Sequencing Players Market Share

3.2.2 Top 10 Clinical Next-Generation Sequencing Players Market Share

3.3 Market Competition Trend

4 Global Clinical Next-Generation Sequencing Market Size by Regions

4.1 Global Clinical Next-Generation Sequencing Revenue and Market Share by Regions

4.2 North America Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

4.3 Europe Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

4.5 South America Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

5 North America Clinical Next-Generation Sequencing Revenue by Countries

5.1 North America Clinical Next-Generation Sequencing Revenue by Countries (2014-2019)

5.2 USA Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

5.3 Canada Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

5.4 Mexico Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

6 Europe Clinical Next-Generation Sequencing Revenue by Countries

6.1 Europe Clinical Next-Generation Sequencing Revenue by Countries (2014-2019)

6.2 Germany Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

6.3 UK Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

6.4 France Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

6.5 Russia Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

6.6 Italy Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Clinical Next-Generation Sequencing Revenue by Countries

7.1 Asia-Pacific Clinical Next-Generation Sequencing Revenue by Countries (2014-2019)

7.2 China Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

7.3 Japan Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

7.4 Korea Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

7.5 India Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

8 South America Clinical Next-Generation Sequencing Revenue by Countries

8.1 South America Clinical Next-Generation Sequencing Revenue by Countries (2014-2019)

8.2 Brazil Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

8.3 Argentina Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

8.4 Colombia Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Clinical Next-Generation Sequencing by Countries

9.1 Middle East and Africa Clinical Next-Generation Sequencing Revenue by Countries (2014-2019)

9.2 Saudi Arabia Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

9.3 UAE Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

9.4 Egypt Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

9.5 Nigeria Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

9.6 South Africa Clinical Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

10 Global Clinical Next-Generation Sequencing Market Segment by Type

10.1 Global Clinical Next-Generation Sequencing Revenue and Market Share by Type (2014-2019)

10.2 Global Clinical Next-Generation Sequencing Market Forecast by Type (2019-2024)

10.3 Targeted Sequencing Revenue Growth Rate (2014-2024)

10.4 Exome Sequencing Revenue Growth Rate (2014-2024)

10.5 Others Revenue Growth Rate (2014-2024)

11 Global Clinical Next-Generation Sequencing Market Segment by Application

11.1 Global Clinical Next-Generation Sequencing Revenue Market Share by Application (2014-2019)

11.2 Clinical Next-Generation Sequencing Market Forecast by Application (2019-2024)

11.3 Hospitals and Clinics Revenue Growth (2014-2019)

11.4 Biopharma Companies Revenue Growth (2014-2019)

11.5 Academic and Research Organizations Revenue Growth (2014-2019)

11.6 Others Revenue Growth (2014-2019)

12 Global Clinical Next-Generation Sequencing Market Size Forecast (2019-2024)

12.1 Global Clinical Next-Generation Sequencing Market Size Forecast (2019-2024)

12.2 Global Clinical Next-Generation Sequencing Market Forecast by Regions (2019-2024)

12.3 North America Clinical Next-Generation Sequencing Revenue Market Forecast (2019-2024)

12.4 Europe Clinical Next-Generation Sequencing Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Clinical Next-Generation Sequencing Revenue Market Forecast (2019-2024)

12.6 South America Clinical Next-Generation Sequencing Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Clinical Next-Generation Sequencing Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Clinical Next-Generation Sequencing Picture

Table Product Specifications of Clinical Next-Generation Sequencing

Table Global Clinical Next-Generation Sequencing and

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery